{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:46:38Z","timestamp":1789519598370,"version":"build-2803163510"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002147"],"award-info":[{"award-number":["82002147"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073618"],"award-info":[{"award-number":["82073618"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2019M662543"],"award-info":[{"award-number":["2019M662543"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Scientific Research Project of Henan Institution of Higher Education","award":["20A330004"],"award-info":[{"award-number":["20A330004"]}]},{"name":"Key Scientific Research Project of Henan Institution of Higher Education","award":["21A310026"],"award-info":[{"award-number":["21A310026"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Enterovirus A71 (EV-A71) is an important causative agent of hand-foot-and-mouth disease (HFMD) associated with enormous healthcare and socioeconomic burden. Although a range of studies about EV-A71 pathogenesis have been well described, the underlying molecular mechanism in terms of innate immune response is still not fully understood, especially the roles of TANK-binding kinase 1 (TBK1) and interferon-regulatory factor 3 (IRF3).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methodology\/principal findings<\/jats:title>\n<jats:p>Here, we applied TBK1 inhibitor and IRF3 agonist, for the first time, to evaluate the antiviral activities of TBK1 and IRF3 <jats:italic>in vivo<\/jats:italic>. We found that, through regulating EV-A71-induced type I interferon (IFN) response, IRF3 agonist effectively alleviated EV-A71-induced illness, while TBK1 inhibitor aggravated disease progression. In addition, EV-A71 replication was suppressed in EVA-71-infected mice administrated with IRF3 agonist. On the other hand, more severe pathological alterations of neuronal degeneration, muscle fiber breaks, fractured or fused alveolar walls, and diffuse congestion occurred in EVA-71-infected mice treated with TBK1 inhibitor administration. Furthermore, we determined the concentrations of interleukin (IL)-6, tumor necrosis factor-alpha (TNF-\u03b1), IL-1\u03b2, monocyte chemotactic protein-1 (MCP-1), and IL-10 in both lungs and brains of mice and found that TBK1 inhibitor promoted EV-A71-induced inflammatory response, while IRF3 agonist alleviated it, which was consistent with clinical manifestations and pathological alterations.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Collectively, our findings suggest that TBK1 and IRF3 are potential therapeutic targets in EV-A71-induced illness.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pntd.0011001","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T18:23:00Z","timestamp":1673374980000},"page":"e0011001","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["TBK1 and IRF3 are potential therapeutic targets in Enterovirus A71-associated diseases"],"prefix":"10.1371","volume":"17","author":[{"given":"Wangquan","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaiyin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5084-5859","authenticated-orcid":true,"given":"Yuefei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangcai","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"issue":"5","key":"pntd.0011001.ref001","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1586\/14760584.2016.1138862","article-title":"EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD)","volume":"15","author":"QY Mao","year":"2016","journal-title":"Expert review of vaccines"},{"issue":"1","key":"pntd.0011001.ref002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12250-018-0071-9","article-title":"Recent Progress on Functional Genomics Research of Enterovirus 71","volume":"34","author":"H Wang","year":"2019","journal-title":"Virologica Sinica"},{"issue":"11","key":"pntd.0011001.ref003","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"T Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"pntd.0011001.ref004","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/17460441.2019.1659241","article-title":"Recent progress and challenges in drug development to fight hand, foot and mouth disease","volume":"15","author":"ZQ Lim","year":"2020","journal-title":"Expert opinion on drug discovery"},{"key":"pntd.0011001.ref005","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.3389\/fmicb.2018.02422","article-title":"Innate Immunity Evasion by Enteroviruses Linked to Epidemic Hand-Foot-Mouth Disease","volume":"9","author":"Y Jin","year":"2018","journal-title":"Frontiers in microbiology"},{"issue":"1","key":"pntd.0011001.ref006","doi-asserted-by":"crossref","first-page":"e2016","DOI":"10.1002\/rmv.2016","article-title":"An update on enterovirus 71 infection and interferon type I response","volume":"29","author":"M Rasti","year":"2019","journal-title":"Rev Med Virol"},{"issue":"2","key":"pntd.0011001.ref007","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"F McNab","year":"2015","journal-title":"Nature reviews Immunology"},{"issue":"4","key":"pntd.0011001.ref008","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"A Iwasaki","year":"2015","journal-title":"Nat Immunol"},{"issue":"2","key":"pntd.0011001.ref009","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"TH Mogensen","year":"2009","journal-title":"Clinical microbiology reviews"},{"issue":"1","key":"pntd.0011001.ref010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/08830185.2010.529976","article-title":"Pathogen recognition by the innate immune system","volume":"30","author":"H Kumar","year":"2011","journal-title":"Int Rev Immunol"},{"issue":"4","key":"pntd.0011001.ref011","article-title":"Antiviral and Inflammatory Cellular Signaling Associated with Enterovirus 71 Infection","volume":"10","author":"Y Jin","year":"2018","journal-title":"Viruses"},{"issue":"7073","key":"pntd.0011001.ref012","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nature04374","article-title":"Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response","volume":"439","author":"G Oganesyan","year":"2006","journal-title":"Nature"},{"issue":"2","key":"pntd.0011001.ref013","doi-asserted-by":"crossref","first-page":"840","DOI":"10.4049\/jimmunol.1301601","article-title":"DOK3 is required for IFN-beta production by enabling TRAF3\/TBK1 complex formation and IRF3 activation","volume":"193","author":"SS Kim","year":"2014","journal-title":"J Immunol"},{"key":"pntd.0011001.ref014","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fimmu.2019.00325","article-title":"Regulating IRFs in IFN Driven Disease","volume":"10","author":"CA Jefferies","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"pntd.0011001.ref015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.immuni.2006.08.009","article-title":"Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors","volume":"25","author":"K Honda","year":"2006","journal-title":"Immunity"},{"issue":"1","key":"pntd.0011001.ref016","doi-asserted-by":"crossref","DOI":"10.3390\/v10010046","article-title":"Distinct Effects of Type I and III Interferons on Enteric Viruses","volume":"10","author":"H Ingle","year":"2018","journal-title":"Viruses"},{"issue":"6","key":"pntd.0011001.ref017","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"JW Schoggins","year":"2011","journal-title":"Current opinion in virology"},{"issue":"6","key":"pntd.0011001.ref018","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.febslet.2013.01.052","article-title":"Negative regulation of TBK1-mediated antiviral immunity","volume":"587","author":"W. Zhao","year":"2013","journal-title":"FEBS letters"},{"issue":"5","key":"pntd.0011001.ref019","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/14728222.2019.1601702","article-title":"TANK-binding kinase 1 as a novel therapeutic target for viral diseases","volume":"23","author":"C Zhao","year":"2019","journal-title":"Expert Opin Ther Targets"},{"issue":"8","key":"pntd.0011001.ref020","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.4049\/jimmunol.2000462","article-title":"IFN Regulatory Factor 3 in Health and Disease","volume":"205","author":"TM Petro","year":"2020","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"12","key":"pntd.0011001.ref021","doi-asserted-by":"crossref","first-page":"6613","DOI":"10.3390\/v7122961","article-title":"Innate Immunity and Immune Evasion by Enterovirus 71","volume":"7","author":"PS Pathinayake","year":"2015","journal-title":"Viruses"},{"issue":"1","key":"pntd.0011001.ref022","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12929-019-0596-8","article-title":"Interplays between Enterovirus A71 and the innate immune system","volume":"26","author":"KR Chen","year":"2019","journal-title":"J Biomed Sci"},{"key":"pntd.0011001.ref023","doi-asserted-by":"crossref","first-page":"615965","DOI":"10.3389\/fmicb.2020.615965","article-title":"The Structure, Function, and Mechanisms of Action of Enterovirus Non-structural Protein 2C","volume":"11","author":"SH Wang","year":"2020","journal-title":"Front Microbiol"},{"issue":"4","key":"pntd.0011001.ref024","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2217\/fmb.12.22","article-title":"Viral and host factors that contribute to pathogenicity of enterovirus 71","volume":"7","author":"HI Huang","year":"2012","journal-title":"Future Microbiol"},{"issue":"16","key":"pntd.0011001.ref025","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1128\/JVI.02491-09","article-title":"The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses","volume":"84","author":"X Lei","year":"2010","journal-title":"Journal of virology"},{"issue":"6","key":"pntd.0011001.ref026","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1128\/JVI.02712-13","article-title":"Enterovirus 2Apro targets MDA5 and MAVS in infected cells","volume":"88","author":"Q Feng","year":"2014","journal-title":"Journal of virology"},{"issue":"1","key":"pntd.0011001.ref027","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1080\/21505594.2021.1882775","article-title":"Sox4 represses host innate immunity to facilitate pathogen infection by hijacking the TLR signaling networks","volume":"12","author":"J Shang","year":"2021","journal-title":"Virulence"},{"issue":"10","key":"pntd.0011001.ref028","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s41423-018-0057-4","article-title":"The methyltransferase PRMT6 attenuates antiviral innate immunity by blocking TBK1-IRF3 signaling","volume":"16","author":"H Zhang","year":"2019","journal-title":"Cell Mol Immunol"},{"issue":"6227","key":"pntd.0011001.ref029","doi-asserted-by":"crossref","first-page":"aaa2630","DOI":"10.1126\/science.aaa2630","article-title":"Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation","volume":"347","author":"S Liu","year":"2015","journal-title":"Science"},{"issue":"24","key":"pntd.0011001.ref030","doi-asserted-by":"crossref","first-page":"E3403","DOI":"10.1073\/pnas.1603269113","article-title":"Structural basis for concerted recruitment and activation of IRF-3 by innate immune adaptor proteins","volume":"113","author":"B Zhao","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"pntd.0011001.ref031","doi-asserted-by":"crossref","first-page":"e0163520","DOI":"10.1371\/journal.pone.0163520","article-title":"Critical Role of IRF-3 in the Direct Regulation of dsRNA-Induced Retinoic Acid-Inducible Gene-I (RIG-I) Expression","volume":"11","author":"R Hayakari","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"pntd.0011001.ref032","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41423-020-0453-4","article-title":"MicroRNA-628-5p Facilitates Enterovirus 71 Infection by Suppressing TRAF3 Signaling","volume":"18","author":"D Li","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"pntd.0011001.ref033","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12985-017-0911-5","article-title":"Pulmonary edema following central nervous system lesions induced by a non- mouse-adapted EV71 strain in neonatal BALB\/c mice","volume":"14","author":"Y Jin","year":"2017","journal-title":"Virol J"},{"key":"pntd.0011001.ref034","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating 50 percent end-points","volume":"27","author":"LJ Reed","year":"1938","journal-title":"Am J Epidemiol"},{"issue":"7","key":"pntd.0011001.ref035","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1158\/1541-7786.MCR-13-0642","article-title":"Evaluating TBK1 as a therapeutic target in cancers with activated IRF3","volume":"12","author":"A Muvaffak","year":"2014","journal-title":"Mol Cancer Res"},{"issue":"15","key":"pntd.0011001.ref036","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.vaccine.2017.01.053","article-title":"A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune response","volume":"35","author":"P Probst","year":"2017","journal-title":"Vaccine"},{"issue":"13","key":"pntd.0011001.ref037","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00333-17","article-title":"Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection","volume":"91","author":"Z Zhang","year":"2017","journal-title":"J Virol"},{"issue":"2","key":"pntd.0011001.ref038","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.20171116","article-title":"Targeting IRF3 as a YAP agonist therapy against gastric cancer","volume":"215","author":"S Jiao","year":"2018","journal-title":"The Journal of experimental medicine"},{"key":"pntd.0011001.ref039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2014.04.014","article-title":"Association of viral replication capacity with the pathogenicity of enterovirus 71","volume":"189","author":"LL Sun","year":"2014","journal-title":"Virus research"},{"key":"pntd.0011001.ref040","doi-asserted-by":"crossref","first-page":"103078","DOI":"10.1016\/j.ebiom.2020.103078","article-title":"Enterovirus genomic load and disease severity among children hospitalised with hand, foot and mouth disease","volume":"62","author":"C Song","year":"2020","journal-title":"EBioMedicine"},{"issue":"7","key":"pntd.0011001.ref041","doi-asserted-by":"crossref","first-page":"e1002826","DOI":"10.1371\/journal.ppat.1002826","article-title":"Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection","volume":"8","author":"S Cordey","year":"2012","journal-title":"PLoS Pathog"},{"issue":"5","key":"pntd.0011001.ref042","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01759-16","article-title":"In Vivo Imaging with Bioluminescent Enterovirus 71 Allows for Real-Time Visualization of Tissue Tropism and Viral Spread","volume":"91","author":"EA Caine","year":"2017","journal-title":"J Virol"},{"issue":"12","key":"pntd.0011001.ref043","doi-asserted-by":"crossref","DOI":"10.3390\/v11121121","article-title":"EV71 Infection Induces IFN\u03b2 Expression in Neural Cells","volume":"11","author":"HI Huang","year":"2019","journal-title":"Viruses"},{"issue":"Pt 12","key":"pntd.0011001.ref044","first-page":"3263","article-title":"Type I interferons protect mice against enterovirus 71 infection","volume":"86","author":"ML Liu","year":"2005","journal-title":"J Gen Virol"},{"key":"pntd.0011001.ref045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.antiviral.2016.09.003","article-title":"Single dose of an adenovirus vectored mouse interferon-\u03b1 protects mice from lethal EV71 challenge","volume":"134","author":"J Sun","year":"2016","journal-title":"Antiviral research"},{"issue":"2","key":"pntd.0011001.ref046","doi-asserted-by":"crossref","first-page":"e0148907","DOI":"10.1371\/journal.pone.0148907","article-title":"Clinical Efficacy of Therapy with Recombinant Human Interferon \u03b11b in Hand, Foot, and Mouth Disease with Enterovirus 71 Infection","volume":"11","author":"X Huang","year":"2016","journal-title":"PloS one"},{"key":"pntd.0011001.ref047","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1038\/ncomms4344","article-title":"Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon","volume":"5","author":"BC Ho","year":"2014","journal-title":"Nat Commun"},{"issue":"12","key":"pntd.0011001.ref048","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/infdis\/jir174","article-title":"Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir","volume":"203","author":"HC Hung","year":"2011","journal-title":"J Infect Dis"},{"key":"pntd.0011001.ref049","article-title":"Anemoside B4 inhibits enterovirus 71 propagation in mice through upregulating 14-3-3 expression and type I interferon responses","author":"NX Kang","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"pntd.0011001.ref050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12879-015-0965-1","article-title":"Cytokine responses and correlations thereof with clinical profiles in children with enterovirus 71 infections","volume":"15","author":"N Ye","year":"2015","journal-title":"BMC Infect Dis"},{"key":"pntd.0011001.ref051","first-page":"876241","article-title":"Cytokine immunopathogenesis of enterovirus 71 brain stem encephalitis","volume":"2012","author":"SM Wang","year":"2012","journal-title":"Clinical & developmental immunology"},{"key":"pntd.0011001.ref052","doi-asserted-by":"crossref","first-page":"9273241","DOI":"10.1155\/2020\/9273241","article-title":"Predicting Severe Enterovirus 71-Infected Hand, Foot, and Mouth Disease: Cytokines and Chemokines","volume":"2020","author":"W Zhang","year":"2020","journal-title":"Mediators Inflamm"},{"issue":"6","key":"pntd.0011001.ref053","doi-asserted-by":"crossref","first-page":"e67430","DOI":"10.1371\/journal.pone.0067430","article-title":"Comparative study of the cytokine\/chemokine response in children with differing disease severity in enterovirus 71-induced hand, foot, and mouth disease","volume":"8","author":"Y Zhang","year":"2013","journal-title":"PloS one"},{"key":"pntd.0011001.ref054","doi-asserted-by":"crossref","first-page":"154765","DOI":"10.1016\/j.cyto.2019.154765","article-title":"Global cytokine\/chemokine profile identifies potential progression prediction indicators in hand-foot-and-mouth disease patients with Enterovirus A71 infections","volume":"123","author":"Y He","year":"2019","journal-title":"Cytokine"},{"issue":"6","key":"pntd.0011001.ref055","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/infdis\/jis446","article-title":"In enterovirus 71 encephalitis with cardio-respiratory compromise, elevated interleukin 1\u03b2, interleukin 1 receptor antagonist, and granulocyte colony-stimulating factor levels are markers of poor prognosis","volume":"206","author":"MJ Griffiths","year":"2012","journal-title":"The Journal of infectious diseases"},{"key":"pntd.0011001.ref056","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcv.2017.08.005","article-title":"IL-10-592 polymorphism is associated with IL-10 expression and severity of enterovirus 71 infection in chinese children","volume":"95","author":"N Zhao","year":"2017","journal-title":"J Clin Virol"},{"issue":"11","key":"pntd.0011001.ref057","doi-asserted-by":"crossref","first-page":"e112676","DOI":"10.1371\/journal.pone.0112676","article-title":"Serum inflammatory cytokine levels correlate with hand-foot-mouth disease severity: a nested serial case-control study","volume":"9","author":"G Duan","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"pntd.0011001.ref058","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/00325481.2018.1416257","article-title":"Serum interleukin-6 levels as an indicator of aseptic meningitis among children with enterovirus 71-induced hand, foot and mouth disease","volume":"130","author":"JY Lee","year":"2018","journal-title":"Postgrad Med"},{"issue":"52","key":"pntd.0011001.ref059","doi-asserted-by":"crossref","first-page":"e18464","DOI":"10.1097\/MD.0000000000018464","article-title":"Characterization of inflammatory cytokine profiles in cerebrospinal fluid of hand, foot, and mouth disease children with enterovirus 71-related encephalitis in Hangzhou, Zhejiang, China","volume":"98","author":"Y Xu","year":"2019","journal-title":"Medicine"},{"issue":"1","key":"pntd.0011001.ref060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40001-018-0313-1","article-title":"Correlation analysis on serum inflammatory cytokine level and neurogenic pulmonary edema for children with severe hand-foot-mouth disease","volume":"23","author":"JF Sun","year":"2018","journal-title":"Eur J Med Res"},{"issue":"1","key":"pntd.0011001.ref061","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/s41598-018-19988-6","article-title":"Cerebrospinal fluid chemokine patterns in children with enterovirus 71-related encephalitis","volume":"8","author":"J Liu","year":"2018","journal-title":"Scientific reports"},{"issue":"7","key":"pntd.0011001.ref062","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/591462","article-title":"Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis","volume":"198","author":"SM Wang","year":"2008","journal-title":"The Journal of infectious diseases"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0011001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T18:23:38Z","timestamp":1673375018000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0011001"}},"subtitle":[],"editor":[{"given":"Yoke Fun","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0011001","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]}}}